Standard Chemical & Pharmaceutical Co. Ltd. (TPE:1720)

TPE:1720 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,594	1,520	2,037	2,259	2,564	1,036
Short-Term Investments	255.15	134.5	60.5	44.36	57.84	308.54
Trading Asset Securities	133.71	157.36	178.29	176.15	134.91	136.56
Cash & Short-Term Investments	1,983	1,812	2,276	2,480	2,757	1,481
Cash Growth	6.28%	-20.37%	-8.24%	-10.06%	86.13%	-12.46%
Accounts Receivable	1,471	1,323	1,263	1,263	1,158	942.84
Other Receivables	7.47	17.29	155.84	216.67	331.82	24.41
Receivables	1,479	1,340	1,419	1,480	1,490	967.25
Inventory	1,600	1,720	1,615	1,386	1,218	893.51
Prepaid Expenses	160.02	126.91	103.09	95.21	86.62	93.16
Other Current Assets	2.45	2.49	5.56	148.27	232.89	166.39
Total Current Assets	5,224	5,002	5,418	5,589	5,784	3,602
Property, Plant & Equipment	4,516	4,389	4,301	3,952	2,955	2,389
Long-Term Investments	1,265	1,208	967.73	844.45	769.34	669.49
Goodwill	173.91	173.91	173.91	173.91	162.24	70.27
Other Intangible Assets	38.76	33.82	40.63	51.08	61.38	18.7
Long-Term Deferred Tax Assets	136.82	132.26	141.31	128.37	141.45	138.59
Other Long-Term Assets	231.13	236.25	146.82	228.68	221.04	161.53
Total Assets	11,585	11,176	11,189	10,968	10,095	7,049
Accounts Payable	633.92	603.07	642.99	686.37	624.35	438.57
Accrued Expenses	236.29	332.43	340.88	290.57	141.95	-
Short-Term Debt	180	110	800	1,350	1,358	566
Current Portion of Long-Term Debt	59.03	59.03	59.03	-	-	-
Current Portion of Leases	27.6	23.75	24.17	21.21	20.35	17.54
Current Income Taxes Payable	278.61	195.82	235.19	222.04	164.07	99.09
Current Unearned Revenue	109.14	94.99	83.21	84	79.12	135.66
Other Current Liabilities	1,003	241.85	185.41	225.65	328.28	393.76
Total Current Liabilities	2,527	1,661	2,371	2,880	2,716	1,651
Long-Term Debt	34.43	163.95	222.97	182	50	-
Long-Term Leases	210.21	203.7	221.72	236.7	239.64	201.66
Long-Term Deferred Tax Liabilities	82.17	85.49	84.27	84.67	83.85	61.99
Other Long-Term Liabilities	8.61	8.77	12.3	0.41	0.53	1.37
Total Liabilities	2,934	2,199	3,051	3,533	3,295	2,144
Common Stock	1,787	1,787	1,787	1,787	1,787	1,787
Additional Paid-In Capital	300.5	300.13	223.89	220.48	204.31	203.27
Retained Earnings	3,599	3,710	3,275	2,862	2,461	1,946
Comprehensive Income & Other	-7.4	108.13	13.18	-115.94	-110.33	29.31
Total Common Equity	5,679	5,905	5,299	4,753	4,342	3,966
Minority Interest	2,972	3,071	2,838	2,682	2,458	939.9
Shareholders' Equity	8,651	8,976	8,137	7,436	6,800	4,906
Total Liabilities & Equity	11,585	11,176	11,189	10,968	10,095	7,049
Total Debt	511.26	560.43	1,328	1,790	1,668	785.2
Net Cash (Debt)	1,471	1,252	947.65	689.98	1,089	696.09
Net Cash Growth	39.62%	32.07%	37.34%	-36.65%	56.47%	3.94%
Net Cash Per Share	8.22	7.00	5.30	3.86	6.09	3.89
Filing Date Shares Outstanding	178.7	178.7	178.7	178.7	178.7	178.7
Total Common Shares Outstanding	178.7	178.7	178.7	178.7	178.7	178.7
Working Capital	2,696	3,341	3,047	2,710	3,068	1,951
Book Value Per Share	31.78	33.05	29.65	26.60	24.30	22.19
Tangible Book Value	5,466	5,697	5,084	4,528	4,118	3,877
Tangible Book Value Per Share	30.59	31.88	28.45	25.34	23.05	21.70
Land	898.54	898.54	770.54	770.54	496.34	420.37
Buildings	2,609	2,421	2,190	2,055	1,819	1,671
Machinery	4,029	3,940	3,738	3,196	2,738	2,168
Construction In Progress	213.56	206.52	345.85	385.15	171.35	86.34

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.